ProXES buys FrymaKoruma from Romaco Group

Romaco Group has announced plans to sell its stake in FrymaKoruma to an umbrella corporation within the Deutsche Beteiligungs AG (DBAG) group.

The umbrella corporation, ProXES, will include both FrymaKoruma and Stephan Machinery. Both companies have strong brands in the food, pharmaceutical and healthcare technology sectors. A clear focus on process technology will ensure a stronger market position under the common umbrella corporation; therefore, ProXES will acquire the entire stake in FrymaKrouma from the Romaco Group.

“During more than 10 years in affiliation with the Romaco Group, FrymaKoruma developed very well. We are pleased to offer a further growth spurt to the company in a group that specialises in process technology. Through this transaction, Romaco will focus even more on the development of its competences, especially in the pharmaceuticals market,” said Paulo Alexandre, CEO of the Romaco Group.

“Within the Romaco Group, we were already able to make use of significant incentives for the development of FrymaKoruma,” said Thomas Merle, director of FrymaKoruma. “We are very pleased that we can now realise previously unknown possibilities within our core business with the help of ProXES and its clear focus on process technology.”

Olaf Pehmöller, CEO of Stephan Machinery, will act as CEO for the ProXES group.